HomeTagsHT-ALZ Therapeutic

HT-ALZ Therapeutic

Biotechnology

Hoth Therapeutics Announces HT-ALZ Therapeutic Shows Cognitive Improvements in Alzheimer’s Disease

PR Newswire - July 13, 2022

Hoth Therapeutics, Inc., a patient-focused biopharmaceutical company, announced proof-of-concept data generated using cognitive and behavioral assessments in an Alzheimer's disease mouse model (aged APP/PS1+/-...

Biotechnology

Hoth Therapeutics Announces HT-ALZ Therapeutic Shows Positive Results – Reduce Amyloid β in Alzheimer’s Disease

PR Newswire - January 5, 2022

Hoth Therapeutics, Inc., a patient-focused biopharmaceutical company, announced proof-of-concept data generated using an Alzheimer's disease mouse model, supporting the therapeutic potential of HT-ALZ. The...